×
0 0 0 0 0 0 0 0
Stock impact report

Recro Pharma Reports Third Quarter 2019 Financial Results

Recro Pharma, Inc (REPH)  More Company Research Source: GlobeNewswire
Last recro pharma, inc earnings: 11/8 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.recropharma.com
PDF CDMO Business Achieves 37% Growth in 2019 Year to Date Revenues; Consolidated Company Achieves Profitability from Operations, Turns Cash Flow Positive and Raises 2019 Revenue Guidance to $98-100 Million FDA Grants Appeal for IV Meloxicam New Drug Application Company Remains on Track to Execute Spin Out of Acute Care Business Segment During the Fourth Quarter of 2019 Company to Host Conference Call Today at 8:00 AM ET MALVERN, Pa., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a pharmaceutical company with a high-performing, revenue generating contract development and manufacturing (CDMO) segment and an Acute Care segment, today reported financial results for the three and nine months ended September 30, 2019. “The CDMO business has continued to deliver record results, generating $81.6 million in year to date revenues, a 37% increase over the comparable nine-month period in 2018, and surpassing our full year 2018 revenues in just nine months,” said Gerri H [Read more]
Impact snapshot Event time: REPH
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
REPH alerts

from News Quantified
Opt-in for
REPH alerts

from News Quantified